1082 related articles for article (PubMed ID: 23788174)
1. Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis.
McLaughlin PJ; Immonen JA; Zagon IS
Exp Biol Med (Maywood); 2013 Jul; 238(7):733-43. PubMed ID: 23788174
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment with the opioid antagonist naltrexone accelerates the remodeling phase of full-thickness wound healing in type 1 diabetic rats.
Immonen JA; Zagon IS; Lewis GS; McLaughlin PJ
Exp Biol Med (Maywood); 2013 Oct; 238(10):1127-35. PubMed ID: 23986225
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats.
McLaughlin PJ; Pothering CA; Immonen JA; Zagon IS
Exp Biol Med (Maywood); 2011 Oct; 236(10):1122-32. PubMed ID: 21917593
[TBL] [Abstract][Full Text] [Related]
4. Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.
Immonen JA; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2014 Oct; 239(10):1300-9. PubMed ID: 25030485
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.
Klocek MS; Sassani JW; McLaughlin PJ; Zagon IS
Exp Eye Res; 2009 Nov; 89(5):686-92. PubMed ID: 19576213
[TBL] [Abstract][Full Text] [Related]
6. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.
Galiano RD; Tepper OM; Pelo CR; Bhatt KA; Callaghan M; Bastidas N; Bunting S; Steinmetz HG; Gurtner GC
Am J Pathol; 2004 Jun; 164(6):1935-47. PubMed ID: 15161630
[TBL] [Abstract][Full Text] [Related]
7. Propranolol improves cutaneous wound healing in streptozotocin-induced diabetic rats.
Romana-Souza B; Nascimento AP; Monte-Alto-Costa A
Eur J Pharmacol; 2009 Jun; 611(1-3):77-84. PubMed ID: 19344703
[TBL] [Abstract][Full Text] [Related]
8. Topical application of substance P promotes wound healing in streptozotocin-induced diabetic rats.
Kant V; Kumar D; Kumar D; Prasad R; Gopal A; Pathak NN; Kumar P; Tandan SK
Cytokine; 2015 May; 73(1):144-55. PubMed ID: 25748837
[TBL] [Abstract][Full Text] [Related]
9. Acceleration of diabetic wound healing by collagen-binding vascular endothelial growth factor in diabetic rat model.
Yan X; Chen B; Lin Y; Li Y; Xiao Z; Hou X; Tan Q; Dai J
Diabetes Res Clin Pract; 2010 Oct; 90(1):66-72. PubMed ID: 20667614
[TBL] [Abstract][Full Text] [Related]
10. Systemically and topically supplemented leptin fails to reconstitute a normal angiogenic response during skin repair in diabetic ob/ob mice.
Stallmeyer B; Pfeilschifter J; Frank S
Diabetologia; 2001 Apr; 44(4):471-9. PubMed ID: 11357478
[TBL] [Abstract][Full Text] [Related]
11. The role of mast cells in cutaneous wound healing in streptozotocin-induced diabetic mice.
Nishikori Y; Shiota N; Okunishi H
Arch Dermatol Res; 2014 Nov; 306(9):823-35. PubMed ID: 25218083
[TBL] [Abstract][Full Text] [Related]
12. Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds.
McLaughlin PJ; Cain JD; Titunick MB; Sassani JW; Zagon IS
Adv Wound Care (New Rochelle); 2017 Sep; 6(9):279-288. PubMed ID: 28894635
[No Abstract] [Full Text] [Related]
13. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis.
Asai J; Takenaka H; Hirakawa S; Sakabe J; Hagura A; Kishimoto S; Maruyama K; Kajiya K; Kinoshita S; Tokura Y; Katoh N
Am J Pathol; 2012 Dec; 181(6):2217-24. PubMed ID: 23138019
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide accelerates wound healing in diabetic rats.
Wang G; Li W; Chen Q; Jiang Y; Lu X; Zhao X
Int J Clin Exp Pathol; 2015; 8(5):5097-104. PubMed ID: 26191204
[TBL] [Abstract][Full Text] [Related]
15. Impaired integration of endothelial progenitor cells in capillaries of diabetic wounds is reversible with vascular endothelial growth factor infusion.
Singh AK; Gudehithlu KP; Patri S; Litbarg NO; Sethupathi P; Arruda JA; Dunea G
Transl Res; 2007 May; 149(5):282-91. PubMed ID: 17466928
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-induced angiogenesis hastens wound healing in diabetic rats.
Kant V; Gopal A; Kumar D; Pathak NN; Ram M; Jangir BL; Tandan SK; Kumar D
J Surg Res; 2015 Feb; 193(2):978-88. PubMed ID: 25454972
[TBL] [Abstract][Full Text] [Related]
17. Nesfatin-1 improves oxidative skin injury in normoglycemic or hyperglycemic rats.
Solmaz A; Bahadır E; Gülçiçek OB; Yiğitbaş H; Çelik A; Karagöz A; Özsavcı D; Şirvancı S; Yeğen BÇ
Peptides; 2016 Apr; 78():1-10. PubMed ID: 26829459
[TBL] [Abstract][Full Text] [Related]
18. Topically applied naltrexone restores corneal reepithelialization in diabetic rats.
Klocek MS; Sassani JW; McLaughlin PJ; Zagon IS
J Ocul Pharmacol Ther; 2007 Apr; 23(2):89-102. PubMed ID: 17444796
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm.
Kwon YW; Heo SC; Jang IH; Jeong GO; Yoon JW; Mun JH; Kim JH
Wound Repair Regen; 2015; 23(4):575-82. PubMed ID: 25973651
[TBL] [Abstract][Full Text] [Related]
20. Topical erythropoietin promotes wound repair in diabetic rats.
Hamed S; Ullmann Y; Masoud M; Hellou E; Khamaysi Z; Teot L
J Invest Dermatol; 2010 Jan; 130(1):287-94. PubMed ID: 19626038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
